{"id":949,"company":{"country":"US","currency":"USD","exchange":"NASDAQ NMS - GLOBAL MARKET","ipo":"2012-12-10","marketCap":2474.111572265625,"name":"Neogenomics Inc","phone":"12397680600.0","outstanding":127.55000305175781,"symbol":"NEO","website":"https://neogenomics.com/","industry":"Health Care"},"price":18.7825,"year":2023,"month":11,"day":18,"weekday":"Saturday","title":"Corporate Governance Practices of Neogenomics Inc","date":"2023-11-18","url":"/posts/2023/11/18/NEO","content":[{"section":"Board Composition","text":"Neogenomics Inc has a well-balanced board composition that includes a majority of independent directors. As of the latest proxy statement, out of the nine directors on the board, six are considered independent. This ensures that the board is able to provide unbiased oversight and make decisions in the best interest of the company and its shareholders. The independent directors bring diverse expertise and experience from various industries, enhancing the overall governance of the company."},{"section":"Executive Compensation","text":"Neogenomics Inc's executive compensation practices are designed to align the interests of executives with those of shareholders. The compensation packages include a mix of base salary, annual bonuses, and long-term incentives such as stock options and restricted stock units. The base salary provides a fixed component, while the annual bonuses are tied to performance goals and metrics, ensuring that executives are incentivized to drive the company's financial and operational success. The long-term incentives further align executive interests with long-term shareholder value creation."},{"section":"","text":""},{"section":"","text":""},{"section":"","text":""},{"section":"","text":""},{"section":"","text":""},{"section":"","text":""}],"tags":["CrossOver55","Long","Health Care"],"news":[{"category":"company","date":1700136060,"headline":"Wall Street Analysts Are Bullish on Top Healthcare Picks","id":123932857,"image":"","symbol":"NEO","publisher":"TipRanks","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3215990663"},{"category":"company","date":1700039198,"headline":"NeoGenomics to Participate at the Piper Sandler 35th Annual Healthcare Conference","id":123891868,"image":"","symbol":"NEO","publisher":"Finnhub","summary":"FT. MYERS - NeoGenomics, Inc. , a leading oncology testing services company, today announced the company will participate in the upcoming Piper Sandler 35th Annual Global Healthcare Conference in New...","url":"https://finnhub.io/api/news?id=ceb5a1cde1b02535ca241bbc59cd231d5a2cd4219d8ff68eafb776dcc19688f3"},{"category":"company","date":1700014440,"headline":"Raymond James Remains a Buy on Neo Performance Materials Inc (NEO)","id":123905055,"image":"","symbol":"NEO","publisher":"TipRanks","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3214319172"},{"category":"company","date":1699953540,"headline":"NeoGenomics Inc's Stock Performance: A Detailed Analysis","id":123864681,"image":"","symbol":"NEO","publisher":"GuruFocus","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3212001306"},{"category":"company","date":1699887317,"headline":"Wall Street Analysts See a 28.17% Upside in NeoGenomics (NEO): Can the Stock Really Move This High?","id":123847138,"image":"https://media.zenfs.com/en/zacks.com/105b2acef7bf0873f24b78932b1fdc3c","symbol":"NEO","publisher":"Yahoo","summary":"The average of price targets set by Wall Street analysts indicates a potential upside of 28.2% in NeoGenomics (NEO). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.","url":"https://finance.yahoo.com/news/wall-street-analysts-see-28-145517921.html"},{"category":"company","date":1699859040,"headline":"Stifel Nicolaus Maintains Their Hold Rating on Neo Performance Materials Inc (NEO)","id":123844233,"image":"","symbol":"NEO","publisher":"TipRanks","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3209868504"},{"category":"company","date":1699596720,"headline":"Neo Energy Metals raises GBP500,000 via subscription of new shares","id":123790953,"image":"","symbol":"NEO","publisher":"Alliance News","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=11toctbcco"},{"category":"company","date":1699445460,"headline":"Analysts Offer Insights on Healthcare Companies: Stoke Therapeutics (STOK), NeoGenomics (NEO) and RegenXBio (RGNX)","id":123725331,"image":"","symbol":"NEO","publisher":"TipRanks","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3201451554"},{"category":"company","date":1699365668,"headline":"NeoGenomics, Inc. (NASDAQ:NEO) Q3 2023 Earnings Call Transcript","id":123706141,"image":"https://s.yimg.com/ny/api/res/1.2/He382QsR3d74LByFHMmOuQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02NzM-/https://media.zenfs.com/en/insidermonkey.com/b7842bfdf308215f98e7f4a3bfa22607","symbol":"NEO","publisher":"Yahoo","summary":"NeoGenomics, Inc. (NASDAQ:NEO) Q3 2023 Earnings Call Transcript November 6, 2023 Operator: Greetings. Welcome to the NeoGenomics Third Quarter 2023 Earnings Call — Third Quarter 2023 Financial Results Conference Call and Webcast. At this time, all participants are in a listen-only mode. Please note this call is being recorded, and an audio replay will be […]","url":"https://finance.yahoo.com/news/neogenomics-inc-nasdaq-neo-q3-140108858.html"},{"category":"company","date":1699356900,"headline":"NeoGenomics’ Strong Performance and Growth Potential: Reasons Behind Analyst’s Buy Rating and Increased Price Target","id":123725332,"image":"","symbol":"NEO","publisher":"TipRanks","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3201425309"},{"category":"company","date":1699345620,"headline":"NeoGenomics (NEO) Gets a Buy from Craig-Hallum","id":123709811,"image":"","symbol":"NEO","publisher":"TipRanks","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3199701776"},{"category":"company","date":1699338900,"headline":"NeoGenomics price target lowered to $22 from $23 at TD Cowen","id":123709812,"image":"","symbol":"NEO","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3199548253"},{"category":"company","date":1699338420,"headline":"Piper Sandler Sticks to Its Buy Rating for NeoGenomics (NEO)","id":123709813,"image":"","symbol":"NEO","publisher":"TipRanks","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3199537843"},{"category":"company","date":1699337160,"headline":"Benchmark Co. Keeps Their Buy Rating on NeoGenomics (NEO)","id":123709814,"image":"","symbol":"NEO","publisher":"TipRanks","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3199515010"},{"category":"company","date":1699336080,"headline":"NeoGenomics price target raised to $17 from $15 at BofA","id":123709815,"image":"","symbol":"NEO","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3199496703"},{"category":"company","date":1699326120,"headline":"What 6 Analyst Ratings Have To Say About NeoGenomics","id":123709816,"image":"","symbol":"NEO","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3200363172"},{"category":"company","date":1699322402,"headline":"Compared to Estimates, NeoGenomics (NEO) Q3 Earnings: A Look at Key Metrics","id":123678347,"image":"https://media.zenfs.com/en/zacks.com/b369e357aa3d42cc28ac674490d4ae83","symbol":"NEO","publisher":"Yahoo","summary":"Although the revenue and EPS for NeoGenomics (NEO) give a sense of how its business performed in the quarter ended September 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.","url":"https://finance.yahoo.com/news/compared-estimates-neogenomics-neo-q3-020002647.html"},{"category":"company","date":1699319040,"headline":"NeoGenomics price target raised to $16 from $15 at BofA","id":123709817,"image":"","symbol":"NEO","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3200157213"},{"category":"company","date":1699306418,"headline":"NeoGenomics Inc (NEO) Reports 18% Revenue Increase in Q3 2023","id":123671916,"image":"https://s.yimg.com/cv/apiv2/social/images/yahoo_default_logo-1200x1200.png","symbol":"NEO","publisher":"Yahoo","summary":"Net loss decreases by 50% and Adjusted EBITDA increases by 129% Year-over-Year","url":"https://finance.yahoo.com/news/neogenomics-inc-neo-reports-18-213338516.html"},{"category":"company","date":1699304700,"headline":"NeoGenomics Reports Third Quarter 2023 Results","id":123671917,"image":"https://media.zenfs.com/en/accesswire.ca/ab5b060e9b8cb180eedd70697f2f17fa","symbol":"NEO","publisher":"Yahoo","summary":"Third Quarter Revenue Increased 18% to $152 MillionFORT MYERS, FL / ACCESSWIRE / November 6, 2023 / NeoGenomics, Inc. (NASDAQ:NEO) (the \"Company\"), a leading oncology testing services company, today announced its third-quarter results for the period ...","url":"https://finance.yahoo.com/news/neogenomics-reports-third-quarter-2023-210500618.html"},{"category":"company","date":1699301100,"headline":"NeoGenomics, Inc. 2023 Q3 - Results - Earnings Call Presentation","id":123673712,"image":"https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png","symbol":"NEO","publisher":"SeekingAlpha","summary":"The following slide deck was published by NeoGenomics, Inc.","url":"https://seekingalpha.com/article/4648199-neogenomics-inc-2023-q3-results-earnings-call-presentation"},{"category":"company","date":1699300983,"headline":"NeoGenomics, Inc (NEO) Q3 2023 Earnings Call Transcript","id":123673714,"image":"https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png","symbol":"NEO","publisher":"SeekingAlpha","summary":"NeoGenomics, Inc (NASDAQ:NASDAQ:NEO) Q3 2023 Earnings Conference Call November 6, 2023 4:30 AM ETCompany ParticipantsKendra Sweeney - VP, IRChris Smith -...","url":"https://seekingalpha.com/article/4648197-neogenomics-inc-neo-q3-2023-earnings-call-transcript"},{"category":"company","date":1699294260,"headline":"NeoGenomics: Q3 Earnings Snapshot","id":123673568,"image":"","symbol":"NEO","publisher":"Associated Press, The","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=x3mjqowowg"},{"category":"company","date":1699264680,"headline":"NeoGenomics Outshines Expectations: A Promising Buy Amid Robust Performance and Sustainable Growth","id":123709818,"image":"","symbol":"NEO","publisher":"TipRanks","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3199054704"},{"category":"company","date":1699255620,"headline":"Earnings Scheduled For November 6, 2023","id":123658977,"image":"","symbol":"NEO","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3197554171"},{"category":"company","date":1699242600,"headline":"NeoGenomics Non-GAAP EPS of $0.00 beats by $0.08, revenue of $152M beats by $10M","id":123673572,"image":"","symbol":"NEO","publisher":"Seeking Alpha","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3198319051"},{"category":"company","date":1699159200,"headline":"Notable earnings after Monday's close","id":123659919,"image":"","symbol":"NEO","publisher":"Seeking Alpha","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3196961756"}]}